$SNDC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VOLITIONRX LTD.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in VOLITIONRX LTD. Get notifications about new insider transactions in VOLITIONRX LTD for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 04 2021 | SNDC | VOLITIONRX LTD | Butera Salvatore Thomas | CEO-Volition Veteri ... | Grant | A | 0.00 | 150,000 | 0 | 150,000 | 0 to 150 K |
| May 04 2021 | SNDC | VOLITIONRX LTD | Butera Salvatore Thomas | CEO-Volition Veteri ... | Sell | D | 0.00 | 15,000 | 0 | 0 | 15 K to 0 (-100.00 %) |
| Mar 29 2021 | SNDC | VOLITIONRX LTD | Nguyen Kim | Director | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
| Mar 29 2021 | SNDC | VOLITIONRX LTD | Brudnick Richard | Director | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
| Feb 08 2021 | SNDC | VOLITIONRX LTD | TERRELL JASON BRADLEY MD | Chief Medical Offic ... | Sell | S | 5.37 | 10,000 | 53,700 | 34,949 | 44.9 K to 34.9 K (-22.25 %) |
| Dec 23 2020 | SNDC | VOLITIONRX LTD | Micallef Jacob Vincent | Chief Scientific Of ... | Option Exercise | G | 4.00 | 125,000 | 500,000 | 125,000 | |
| Dec 23 2020 | SNDC | VOLITIONRX LTD | Micallef Jacob Vincent | Chief Scientific Of ... | Option Exercise | G | 4.00 | 125,000 | 500,000 | 0 | |
| Dec 23 2020 | SNDC | VOLITIONRX LTD | Vanston David Cecil | Chief Financial Off ... | Option Exercise | G | 3.25 | 50,000 | 162,500 | 50,000 | |
| Dec 23 2020 | SNDC | VOLITIONRX LTD | Vanston David Cecil | Chief Financial Off ... | Option Exercise | G | 3.25 | 50,000 | 162,500 | 0 | |
| Dec 23 2020 | SNDC | VOLITIONRX LTD | Vanston David Cecil | Chief Financial Off ... | Option Exercise | G | 4.00 | 60,000 | 240,000 | 60,000 | |
| Dec 23 2020 | SNDC | VOLITIONRX LTD | Vanston David Cecil | Chief Financial Off ... | Option Exercise | G | 4.00 | 60,000 | 240,000 | 0 | |
| Dec 04 2020 | SNDC | VOLITIONRX LTD | TERRELL JASON BRADLEY MD | Chief Medical Offic ... | Sell | S | 3.40 | 10,000 | 34,000 | 44,949 | 54.9 K to 44.9 K (-18.20 %) |
| Dec 03 2020 | SNDC | VOLITIONRX LTD | Butera Salvatore Thomas | Director | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
| Dec 03 2020 | SNDC | VOLITIONRX LTD | Butera Salvatore Thomas | Director | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
| Nov 19 2020 | SNDC | VOLITIONRX LTD | TERRELL JASON BRADLEY MD | Chief Medical Offic ... | Sell | S | 3.45 | 200 | 690 | 54,949 | 55.1 K to 54.9 K (-0.36 %) |
| Nov 19 2020 | SNDC | VOLITIONRX LTD | TERRELL JASON BRADLEY MD | Chief Medical Offic ... | Sell | S | 3.35 | 3,229 | 10,817 | 55,149 | 58.4 K to 55.1 K (-5.53 %) |
| Nov 19 2020 | SNDC | VOLITIONRX LTD | TERRELL JASON BRADLEY MD | Chief Medical Offic ... | Sell | S | 3.40 | 1,571 | 5,341 | 58,378 | 59.9 K to 58.4 K (-2.62 %) |
| Sep 18 2020 | SNDC | VOLITIONRX LTD | TERRELL JASON BRADLEY MD | Chief Medical Offic ... | Option Exercise | M | 2.47 | 25,000 | 61,750 | 0 | |
| Sep 18 2020 | SNDC | VOLITIONRX LTD | TERRELL JASON BRADLEY MD | Chief Medical Offic ... | Buy | M | 2.47 | 25,000 | 61,750 | 59,949 | 34.9 K to 59.9 K (+71.53 %) |
| Sep 18 2020 | SNDC | VOLITIONRX LTD | TERRELL JASON BRADLEY MD | Chief Medical Offic ... | Sell | S | 3.23 | 19,500 | 62,985 | 34,949 | 54.4 K to 34.9 K (-35.81 %) |
| Sep 10 2020 | SNDC | VOLITIONRX LTD | Faulkes Martin Charles | Director | Sell | S | 3.21 | 65,000 | 208,650 | 1,505,943 | 1.6 M to 1.5 M (-4.14 %) |
| Aug 19 2020 | SNDC | VOLITIONRX LTD | Gaetan Michel | Option Exercise | M | 3.00 | 2,500 | 7,500 | 0 | ||
| Aug 19 2020 | SNDC | VOLITIONRX LTD | Gaetan Michel | Option Exercise | M | 2.50 | 2,500 | 6,250 | 0 | ||
| Aug 19 2020 | SNDC | VOLITIONRX LTD | Gaetan Michel | Payment of Exercise | F | 3.50 | 2,143 | 7,501 | 1,071 | 3.2 K to 1.1 K (-66.68 %) | |
| Aug 19 2020 | SNDC | VOLITIONRX LTD | Gaetan Michel | Buy | M | 3.00 | 2,500 | 7,500 | 3,214 | 714 to 3.2 K (+350.14 %) | |
| Aug 19 2020 | SNDC | VOLITIONRX LTD | Gaetan Michel | Payment of Exercise | F | 3.50 | 1,786 | 6,251 | 714 | 2.5 K to 714 (-71.44 %) | |
| Aug 19 2020 | SNDC | VOLITIONRX LTD | Gaetan Michel | Buy | M | 2.50 | 2,500 | 6,250 | 2,500 | 0 to 2.5 K | |
| Aug 14 2020 | SNDC | VOLITIONRX LTD | Innes Guy Archibald | Director | Option Exercise | M | 3.00 | 15,000 | 45,000 | 0 | |
| Aug 14 2020 | SNDC | VOLITIONRX LTD | Innes Guy Archibald | Director | Option Exercise | M | 3.00 | 15,000 | 45,000 | 0 | |
| Aug 14 2020 | SNDC | VOLITIONRX LTD | Innes Guy Archibald | Director | Option Exercise | M | 2.50 | 15,000 | 37,500 | 0 | |
| Aug 14 2020 | SNDC | VOLITIONRX LTD | Innes Guy Archibald | Director | Option Exercise | M | 2.50 | 15,000 | 37,500 | 0 | |
| Aug 14 2020 | SNDC | VOLITIONRX LTD | Innes Guy Archibald | Director | Buy | M | 3.00 | 15,000 | 45,000 | 1,384,975 | 1.4 M to 1.4 M (+1.09 %) |
| Aug 14 2020 | SNDC | VOLITIONRX LTD | Innes Guy Archibald | Director | Buy | M | 3.00 | 15,000 | 45,000 | 1,384,975 | 1.4 M to 1.4 M (+1.09 %) |
| Aug 14 2020 | SNDC | VOLITIONRX LTD | Innes Guy Archibald | Director | Buy | M | 2.50 | 15,000 | 37,500 | 1,369,975 | 1.4 M to 1.4 M (+1.11 %) |
| Aug 14 2020 | SNDC | VOLITIONRX LTD | Innes Guy Archibald | Director | Buy | M | 2.50 | 15,000 | 37,500 | 1,369,975 | 1.4 M to 1.4 M (+1.11 %) |
| Aug 12 2020 | SNDC | VOLITIONRX LTD | Micallef Jacob Vincent | Chief Scientific Of ... | Option Exercise | M | 3.00 | 65,000 | 195,000 | 0 | |
| Aug 12 2020 | SNDC | VOLITIONRX LTD | Micallef Jacob Vincent | Chief Scientific Of ... | Option Exercise | M | 2.50 | 65,000 | 162,500 | 0 | |
| Aug 12 2020 | SNDC | VOLITIONRX LTD | Micallef Jacob Vincent | Chief Scientific Of ... | Payment of Exercise | F | 3.50 | 60,080 | 210,280 | 100,928 | 161 K to 100.9 K (-37.31 %) |
| Aug 12 2020 | SNDC | VOLITIONRX LTD | Micallef Jacob Vincent | Chief Scientific Of ... | Buy | M | 3.00 | 65,000 | 195,000 | 161,008 | 96 K to 161 K (+67.70 %) |
| Aug 12 2020 | SNDC | VOLITIONRX LTD | Micallef Jacob Vincent | Chief Scientific Of ... | Payment of Exercise | F | 3.50 | 55,158 | 193,053 | 96,008 | 151.2 K to 96 K (-36.49 %) |
| Aug 12 2020 | SNDC | VOLITIONRX LTD | Micallef Jacob Vincent | Chief Scientific Of ... | Buy | M | 2.50 | 65,000 | 162,500 | 151,166 | 86.2 K to 151.2 K (+75.44 %) |
| Aug 06 2020 | SNDC | VOLITIONRX LTD | TERRELL JASON BRADLEY MD | Chief Medical Offic ... | Option Exercise | M | 3.00 | 12,500 | 37,500 | 0 | |
| Aug 06 2020 | SNDC | VOLITIONRX LTD | TERRELL JASON BRADLEY MD | Chief Medical Offic ... | Option Exercise | M | 2.50 | 12,500 | 31,250 | 0 | |
| Aug 06 2020 | SNDC | VOLITIONRX LTD | TERRELL JASON BRADLEY MD | Chief Medical Offic ... | Payment of Exercise | F | 3.55 | 10,971 | 38,947 | 54,449 | 65.4 K to 54.4 K (-16.77 %) |
| Aug 06 2020 | SNDC | VOLITIONRX LTD | TERRELL JASON BRADLEY MD | Chief Medical Offic ... | Buy | M | 3.00 | 12,500 | 37,500 | 65,420 | 52.9 K to 65.4 K (+23.62 %) |
| Aug 06 2020 | SNDC | VOLITIONRX LTD | TERRELL JASON BRADLEY MD | Chief Medical Offic ... | Payment of Exercise | F | 3.55 | 9,580 | 34,009 | 52,920 | 62.5 K to 52.9 K (-15.33 %) |
| Aug 06 2020 | SNDC | VOLITIONRX LTD | TERRELL JASON BRADLEY MD | Chief Medical Offic ... | Buy | M | 2.50 | 12,500 | 31,250 | 62,500 | 50 K to 62.5 K (+25.00 %) |
| Jul 28 2020 | SNDC | VOLITIONRX LTD | Micallef Jacob Vincent | Chief Scientific Of ... | Option Exercise | G | 4.00 | 55,000 | 220,000 | 55,000 | |
| Jul 28 2020 | SNDC | VOLITIONRX LTD | Micallef Jacob Vincent | Chief Scientific Of ... | Option Exercise | G | 4.00 | 55,000 | 220,000 | 0 | |
| Jul 28 2020 | SNDC | VOLITIONRX LTD | Micallef Jacob Vincent | Chief Scientific Of ... | Option Exercise | G | 3.00 | 65,000 | 195,000 | 65,000 | |
| Jul 28 2020 | SNDC | VOLITIONRX LTD | Micallef Jacob Vincent | Chief Scientific Of ... | Option Exercise | G | 2.50 | 65,000 | 162,500 | 65,000 | |
| Jul 28 2020 | SNDC | VOLITIONRX LTD | Micallef Jacob Vincent | Chief Scientific Of ... | Option Exercise | G | 3.00 | 65,000 | 195,000 | 0 | |
| Jul 28 2020 | SNDC | VOLITIONRX LTD | Micallef Jacob Vincent | Chief Scientific Of ... | Option Exercise | G | 2.50 | 65,000 | 162,500 | 0 | |
| Jul 23 2020 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | M | 3.00 | 50,000 | 150,000 | 0 | |
| Jul 23 2020 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | M | 2.50 | 50,000 | 125,000 | 0 | |
| Jul 23 2020 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Payment of Exercise | F | 3.95 | 43,627 | 172,327 | 1,142,373 | 1.2 M to 1.1 M (-3.68 %) |
| Jul 23 2020 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Buy | M | 3.00 | 50,000 | 150,000 | 1,186,000 | 1.1 M to 1.2 M (+4.40 %) |
| Jul 23 2020 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Payment of Exercise | F | 3.95 | 40,273 | 159,078 | 1,136,000 | 1.2 M to 1.1 M (-3.42 %) |
| Jul 23 2020 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Buy | M | 2.50 | 50,000 | 125,000 | 1,176,273 | 1.1 M to 1.2 M (+4.44 %) |
| Jul 23 2020 | SNDC | VOLITIONRX LTD | Faulkes Martin Charles | Director | Option Exercise | M | 3.00 | 30,000 | 90,000 | 0 | |
| Jul 23 2020 | SNDC | VOLITIONRX LTD | Faulkes Martin Charles | Director | Option Exercise | M | 2.50 | 30,000 | 75,000 | 0 | |
| Jul 23 2020 | SNDC | VOLITIONRX LTD | Faulkes Martin Charles | Director | Payment of Exercise | F | 3.95 | 26,177 | 103,399 | 1,570,943 | 1.6 M to 1.6 M (-1.64 %) |
| Jul 23 2020 | SNDC | VOLITIONRX LTD | Faulkes Martin Charles | Director | Buy | M | 3.00 | 30,000 | 90,000 | 1,597,120 | 1.6 M to 1.6 M (+1.91 %) |
| Jul 23 2020 | SNDC | VOLITIONRX LTD | Faulkes Martin Charles | Director | Payment of Exercise | F | 3.95 | 24,164 | 95,448 | 1,567,120 | 1.6 M to 1.6 M (-1.52 %) |
| Jul 23 2020 | SNDC | VOLITIONRX LTD | Faulkes Martin Charles | Director | Buy | M | 2.50 | 30,000 | 75,000 | 1,591,284 | 1.6 M to 1.6 M (+1.92 %) |
| Jul 23 2020 | SNDC | VOLITIONRX LTD | Rootsaert Rodney Gerard | Secretary | Option Exercise | M | 3.00 | 30,000 | 90,000 | 0 | |
| Jul 23 2020 | SNDC | VOLITIONRX LTD | Rootsaert Rodney Gerard | Secretary | Option Exercise | M | 2.50 | 30,000 | 75,000 | 0 | |
| Jul 23 2020 | SNDC | VOLITIONRX LTD | Rootsaert Rodney Gerard | Secretary | Payment of Exercise | F | 3.95 | 25,816 | 101,973 | 20,398 | 46.2 K to 20.4 K (-55.86 %) |
| Jul 23 2020 | SNDC | VOLITIONRX LTD | Rootsaert Rodney Gerard | Secretary | Buy | M | 3.00 | 30,000 | 90,000 | 46,214 | 16.2 K to 46.2 K (+185.03 %) |
| Jul 23 2020 | SNDC | VOLITIONRX LTD | Rootsaert Rodney Gerard | Secretary | Payment of Exercise | F | 3.95 | 23,614 | 93,275 | 16,214 | 39.8 K to 16.2 K (-59.29 %) |
| Jul 23 2020 | SNDC | VOLITIONRX LTD | Rootsaert Rodney Gerard | Secretary | Buy | M | 2.50 | 30,000 | 75,000 | 39,828 | 9.8 K to 39.8 K (+305.25 %) |
| May 22 2020 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Buy | P | 2.75 | 4,000 | 11,000 | 1,126,273 | 1.1 M to 1.1 M (+0.36 %) |
| Apr 15 2020 | SNDC | VOLITIONRX LTD | Barnes Phillip | Director | Option Exercise | A | 3.60 | 15,000 | 54,000 | 15,000 | |
| Apr 15 2020 | SNDC | VOLITIONRX LTD | Innes Guy Archibald | Director | Option Exercise | A | 3.60 | 25,000 | 90,000 | 25,000 | |
| Apr 15 2020 | SNDC | VOLITIONRX LTD | Colman Alan | Director | Option Exercise | A | 3.60 | 30,000 | 108,000 | 30,000 | |
| Apr 15 2020 | SNDC | VOLITIONRX LTD | Futcher Edward | Director | Grant | A | 0.00 | 11,250 | 0 | 38,250 | 27 K to 38.3 K (+41.67 %) |
| Apr 15 2020 | SNDC | VOLITIONRX LTD | TERRELL JASON BRADLEY MD | Chief Medical Offic ... | Option Exercise | A | 3.60 | 5,000 | 18,000 | 5,000 | |
| Apr 15 2020 | SNDC | VOLITIONRX LTD | TERRELL JASON BRADLEY MD | Chief Medical Offic ... | Option Exercise | A | 3.60 | 55,000 | 198,000 | 55,000 | |
| Apr 15 2020 | SNDC | VOLITIONRX LTD | Kway Jasmine | CEO-Singapore Volit ... | Option Exercise | A | 3.60 | 55,000 | 198,000 | 55,000 | |
| Apr 15 2020 | SNDC | VOLITIONRX LTD | Rootsaert Rodney Gerard | Secretary | Option Exercise | A | 3.60 | 55,000 | 198,000 | 55,000 | |
| Apr 15 2020 | SNDC | VOLITIONRX LTD | Vanston David Cecil | Chief Financial Off ... | Option Exercise | A | 3.60 | 60,000 | 216,000 | 60,000 | |
| Apr 15 2020 | SNDC | VOLITIONRX LTD | Faulkes Martin Charles | Director | Option Exercise | A | 3.60 | 70,000 | 252,000 | 70,000 | |
| Apr 15 2020 | SNDC | VOLITIONRX LTD | Micallef Jacob Vincent | Chief Scientific Of ... | Option Exercise | A | 3.60 | 70,000 | 252,000 | 70,000 | |
| Apr 15 2020 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | A | 3.60 | 85,000 | 306,000 | 85,000 | |
| Feb 27 2020 | SNDC | VOLITIONRX LTD | TERRELL JASON BRADLEY MD | Chief Medical Offic ... | Option Exercise | A | 2.47 | 125,000 | 308,750 | 0 | |
| Jan 14 2020 | SNDC | VOLITIONRX LTD | TERRELL JASON BRADLEY MD | Chief Medical Offic ... | Sell | D | 4.79 | 11,364 | 54,434 | 50,000 | 61.4 K to 50 K (-18.52 %) |
| Dec 18 2019 | SNDC | VOLITIONRX LTD | Vanston David Cecil | Chief Financial Off ... | Option Exercise | A | 5.00 | 66,533 | 332,665 | 100,000 | |
| Dec 18 2019 | SNDC | VOLITIONRX LTD | Vanston David Cecil | Chief Financial Off ... | Option Exercise | D | 5.00 | 66,533 | 332,665 | 33,467 | |
| Dec 18 2019 | SNDC | VOLITIONRX LTD | Rootsaert Rodney Gerard | Secretary | Option Exercise | A | 5.00 | 60,000 | 300,000 | 60,000 | |
| Dec 18 2019 | SNDC | VOLITIONRX LTD | Rootsaert Rodney Gerard | Secretary | Option Exercise | D | 5.00 | 60,000 | 300,000 | 0 | |
| Dec 18 2019 | SNDC | VOLITIONRX LTD | Faulkes Martin Charles | Director | Option Exercise | A | 5.00 | 66,533 | 332,665 | 100,000 | |
| Dec 18 2019 | SNDC | VOLITIONRX LTD | Faulkes Martin Charles | Director | Option Exercise | D | 5.00 | 66,533 | 332,665 | 33,467 | |
| Dec 18 2019 | SNDC | VOLITIONRX LTD | Micallef Jacob Vincent | Chief Scientific Of ... | Option Exercise | A | 5.00 | 66,533 | 332,665 | 70,000 | |
| Dec 18 2019 | SNDC | VOLITIONRX LTD | Micallef Jacob Vincent | Chief Scientific Of ... | Option Exercise | D | 5.00 | 66,533 | 332,665 | 3,467 | |
| Dec 06 2019 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Buy | P | 4.24 | 1,100 | 4,664 | 1,122,273 | 1.1 M to 1.1 M (+0.10 %) |
| Oct 18 2019 | SNDC | VOLITIONRX LTD | Eight Corp Ltd | 10% Owner | Buy | P | 5.69 | 50,000 | 284,570 | 11,706,913 | 11.7 M to 11.7 M (+0.43 %) |
| Sep 30 2019 | SNDC | VOLITIONRX LTD | Eight Corp Ltd | 10% Owner | Sell | S | 6.03 | 46,238 | 278,792 | 11,656,913 | 11.7 M to 11.7 M (-0.40 %) |
| Aug 28 2019 | SNDC | VOLITIONRX LTD | Faulkes Martin Charles | Director | Buy | P | 3.75 | 10,000 | 37,500 | 1,561,284 | 1.6 M to 1.6 M (+0.64 %) |
| Aug 16 2019 | SNDC | VOLITIONRX LTD | Faulkes Martin Charles | Director | Buy | P | 3.94 | 50,000 | 197,000 | 1,551,284 | 1.5 M to 1.6 M (+3.33 %) |
| Jul 01 2019 | SNDC | VOLITIONRX LTD | TERRELL JASON BRADLEY MD | Chief Medical Offic ... | Option Exercise | A | 2.47 | 125,000 | 308,750 | 125,000 | |
| Jul 01 2019 | SNDC | VOLITIONRX LTD | TERRELL JASON BRADLEY MD | Chief Medical Offic ... | Option Exercise | D | 2.47 | 125,000 | 308,750 | 0 | |
| Jun 13 2019 | SNDC | VOLITIONRX LTD | Faulkes Martin Charles | Director | Buy | P | 3.14 | 10,000 | 31,400 | 1,501,284 | 1.5 M to 1.5 M (+0.67 %) |
| Jun 13 2019 | SNDC | VOLITIONRX LTD | Faulkes Martin Charles | Director | Buy | P | 3.10 | 69,269 | 214,734 | 1,491,284 | 1.4 M to 1.5 M (+4.87 %) |
| Jun 12 2019 | SNDC | VOLITIONRX LTD | Faulkes Martin Charles | Director | Buy | P | 3.02 | 70,731 | 213,608 | 1,422,015 | 1.4 M to 1.4 M (+5.23 %) |
| Jun 12 2019 | SNDC | VOLITIONRX LTD | Faulkes Martin Charles | Director | Buy | P | 3.02 | 70,731 | 213,608 | 1,422,015 | 1.4 M to 1.4 M (+5.23 %) |
| Feb 27 2019 | SNDC | VOLITIONRX LTD | Micallef Jacob Vincent | Chief Scientific Of ... | Option Exercise | X | 2.20 | 11,000 | 24,200 | 0 | |
| Feb 27 2019 | SNDC | VOLITIONRX LTD | Micallef Jacob Vincent | Chief Scientific Of ... | Buy | X | 2.20 | 11,000 | 24,200 | 22,000 | 11 K to 22 K (+100.00 %) |
| Feb 13 2019 | SNDC | VOLITIONRX LTD | Innes Guy Archibald | Director | Option Exercise | A | 3.25 | 25,000 | 81,250 | 25,000 | |
| Feb 13 2019 | SNDC | VOLITIONRX LTD | Skaff Habib | Director | Option Exercise | A | 3.25 | 15,000 | 48,750 | 15,000 | |
| Feb 13 2019 | SNDC | VOLITIONRX LTD | Micallef Jacob Vincent | Chief Scientific Of ... | Option Exercise | A | 3.25 | 50,000 | 162,500 | 50,000 | |
| Feb 13 2019 | SNDC | VOLITIONRX LTD | Faulkes Martin Charles | Director | Option Exercise | A | 3.25 | 50,000 | 162,500 | 50,000 | |
| Feb 13 2019 | SNDC | VOLITIONRX LTD | Vanston David Cecil | Chief Financial Off ... | Option Exercise | A | 3.25 | 50,000 | 162,500 | 50,000 | |
| Feb 13 2019 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | A | 3.25 | 50,000 | 162,500 | 50,000 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | A | 4.00 | 55,000 | 220,000 | 55,000 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | D | 4.00 | 55,000 | 220,000 | 0 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | A | 3.00 | 50,000 | 150,000 | 50,000 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | A | 2.50 | 50,000 | 125,000 | 50,000 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | D | 3.00 | 50,000 | 150,000 | 0 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | D | 2.50 | 50,000 | 125,000 | 0 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | Micallef Jacob Vincent | Chief Scientific Of ... | Option Exercise | A | 4.00 | 55,000 | 220,000 | 55,000 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | Micallef Jacob Vincent | Chief Scientific Of ... | Option Exercise | D | 4.00 | 55,000 | 220,000 | 0 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | Micallef Jacob Vincent | Chief Scientific Of ... | Option Exercise | A | 3.00 | 65,000 | 195,000 | 65,000 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | Micallef Jacob Vincent | Chief Scientific Of ... | Option Exercise | A | 2.50 | 65,000 | 162,500 | 65,000 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | Micallef Jacob Vincent | Chief Scientific Of ... | Option Exercise | D | 3.00 | 65,000 | 195,000 | 0 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | Micallef Jacob Vincent | Chief Scientific Of ... | Option Exercise | D | 2.50 | 65,000 | 162,500 | 0 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | TERRELL JASON BRADLEY MD | Chief Medical Offic ... | Option Exercise | A | 3.00 | 12,500 | 37,500 | 12,500 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | TERRELL JASON BRADLEY MD | Chief Medical Offic ... | Option Exercise | A | 2.50 | 12,500 | 31,250 | 12,500 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | TERRELL JASON BRADLEY MD | Chief Medical Offic ... | Option Exercise | D | 3.00 | 12,500 | 37,500 | 0 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | TERRELL JASON BRADLEY MD | Chief Medical Offic ... | Option Exercise | D | 2.50 | 12,500 | 31,250 | 0 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | Faulkes Martin Charles | Director | Option Exercise | A | 4.00 | 40,000 | 160,000 | 40,000 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | Faulkes Martin Charles | Director | Option Exercise | D | 4.00 | 40,000 | 160,000 | 0 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | Faulkes Martin Charles | Director | Option Exercise | A | 3.00 | 30,000 | 90,000 | 30,000 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | Faulkes Martin Charles | Director | Option Exercise | A | 2.50 | 30,000 | 75,000 | 30,000 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | Faulkes Martin Charles | Director | Option Exercise | D | 3.00 | 30,000 | 90,000 | 0 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | Faulkes Martin Charles | Director | Option Exercise | D | 2.50 | 30,000 | 75,000 | 0 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | Rootsaert Rodney Gerard | Secretary | Option Exercise | A | 4.00 | 35,000 | 140,000 | 35,000 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | Rootsaert Rodney Gerard | Secretary | Option Exercise | D | 4.00 | 35,000 | 140,000 | 0 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | Rootsaert Rodney Gerard | Secretary | Option Exercise | A | 3.00 | 30,000 | 90,000 | 30,000 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | Rootsaert Rodney Gerard | Secretary | Option Exercise | A | 2.50 | 30,000 | 75,000 | 30,000 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | Rootsaert Rodney Gerard | Secretary | Option Exercise | D | 3.00 | 30,000 | 90,000 | 0 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | Rootsaert Rodney Gerard | Secretary | Option Exercise | D | 2.50 | 30,000 | 75,000 | 0 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | Colman Alan | Director | Option Exercise | A | 4.00 | 10,000 | 40,000 | 10,000 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | Colman Alan | Director | Option Exercise | D | 4.00 | 10,000 | 40,000 | 0 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | Innes Guy Archibald | Director | Option Exercise | A | 4.00 | 15,000 | 60,000 | 15,000 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | Innes Guy Archibald | Director | Option Exercise | D | 4.00 | 15,000 | 60,000 | 0 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | Innes Guy Archibald | Director | Option Exercise | A | 3.00 | 15,000 | 45,000 | 15,000 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | Innes Guy Archibald | Director | Option Exercise | A | 2.50 | 15,000 | 37,500 | 15,000 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | Innes Guy Archibald | Director | Option Exercise | D | 3.00 | 15,000 | 45,000 | 0 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | Innes Guy Archibald | Director | Option Exercise | D | 2.50 | 15,000 | 37,500 | 0 | |
| Dec 21 2018 | SNDC | VOLITIONRX LTD | Gaetan Michel | Option Exercise | A | 4.00 | 2,000 | 8,000 | 2,000 |